Evidence map›Paper›PMID 32537652›Full record

ArticleClinical science (London, England : 1979)2020

UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.

Brahmchetna Bedi, Kuo-Chuan Lin, Nicholas M Maurice, Zhihong Yuan, Kaiser Bijli, Michael Koval, C Michael Hart, Joanna B Goldberg, Arlene Stecenko, Ruxana T Sadikot

Open access · hybridAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Unleashing AdipoRon's Potential: A Fresh Approach to TackleJournal of inflammation research · 2024
    Article
  5. HowInternational journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Brahmchetna BediDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Kuo-Chuan LinDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Nicholas M MauriceDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Zhihong YuanDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Kaiser BijliDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Michael KovalDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
C Michael HartDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Joanna B GoldbergDivision of Pediatrics, Cystic Fibrosis, Emory University, Atlanta, GA 30322, U.S.A.
Arlene StecenkoDivision of Pediatrics, Cystic Fibrosis, Emory University, Atlanta, GA 30322, U.S.A.
Ruxana T SadikotDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA 30322, U.S.A.
Emory University · USCystic Fibrosis Foundation · US

Funding

How HIV-related proteins increase the susceptibility to lung injury despite anti-retroviral therapyR01HL144478 · NHLBI · EMORY UNIVERSITY · PI GUIDOT, DAVID MARSHALL, SADIKOT, RUXANA T · 2019 to 2022
$1.6M
TREM-1 in Lung Immune ResponseI01BX001786 · VA · VETERANS HEALTH ADMINISTRATION · PI Ruxana T Sadikot · 2013 to 2026
–
BLRD VA I01 BX001786NHLBI NIH HHS R01 HL144478
6 · The paper itself

Abstract

Cystic fibrosis (CF) is a progressive multiorgan autosomal recessive disease with devastating impact on the lungs caused by derangements of the CF transmembrane conductance regulator (CFTR) gene. Morbidity and mortality are caused by the triad of impaired mucociliary clearance, microbial infections and chronic inflammation. Pseudomonas aeruginosa is the main respiratory pathogen in individuals with CF infecting most patients in later stages. Despite its recognized clinical impact, molecular mechanisms that underlie P. aeruginosa pathogenesis and the host response to P. aeruginosa infection remain incompletely understood. The nuclear hormone receptor peroxisome proliferator-activated receptor (PPAR) γ (PPARγ), has shown to be reduced in CF airways. In the present study, we sought to investigate the upstream mechanisms repressing PPARγ expression and its impact on airway epithelial host defense. Endoplasmic reticulum-stress (ER-stress) triggered unfolded protein response (UPR) activated by misfolded CFTR and P. aeruginosa infection contributed to attenuated expression of PPARγ. Specifically, the protein kinase RNA (PKR)-like ER kinase (PERK) signaling pathway led to the enhanced expression of the CCAAT-enhancer-binding-protein homologous protein (CHOP). CHOP induction led to the repression of PPARγ expression. Mechanistically, we showed that CHOP induction mediated PPARγ attenuation, impacted the innate immune function of normal and ∆F508 primary airway epithelial cells by reducing expression of antimicrobial peptide (AMP) and paraoxanse-2 (PON-2), as well as enhancing IL-8 expression. Furthermore, mitochondrial reactive oxygen species production (mt-ROS) and ER-stress positive feedforward loop also dysregulated mitochondrial bioenergetics. Additionally, our findings implicate that PPARγ agonist pioglitazone (PIO) has beneficial effect on the host at the multicellular level ranging from host defense to mitochondrial re-energization.

Indexed as

Unfolded Protein ResponseA549 CellsAryldialkylphosphatasebeta-DefensinsCystic FibrosisEndoplasmic Reticulum StressEpithelial CellsHost-Pathogen InteractionsHumansImmunity, InnateInterleukin-8MitochondriaPioglitazonePPAR gammaPseudomonas aeruginosaPseudomonas InfectionsAryldialkylphosphatasebeta-DefensinsCXCL8 protein, humanDDIT3 protein, humanDEFB1 protein, humanInterleukin-8PioglitazonePON2 protein, humanPPAR gammaPPARG protein, humanTranscription Factor CHOPantimicrobial peptidesCystic Fibrosiscystic fibrosis transmembrane conductance regulatorER stresshost-pathogen interactionsPPARgamma

Identifiers

PMID32537652
PMCPMC8240499
OpenAlexW3034895956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.